tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA

Iovance Biotherapeutics (IOVA) Revenue

Compare
3,954 Followers

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had a revenue of 67.45M in the quarter ending Sep 30, 2025, with 12.52%. This bring the company's revenue in the last twelve months to 250.43M, Decreased 3.69%. In the fiscal year ending Dec 31, 2024, Iovance Biotherapeutics had annual revenue of 164.07M with 13698.99% growth.
Revenue (ttm)
250.43M
Revenue Growth
175.62%
P/S Ratio
5.71
Revenue/Employee
$195,788
Employees
838
Market Cap
$936.84M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
164.07M162.88M+13,799.00%
Dec 31, 2023
1.19M-118,900,000.00%
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017